<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02504554</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00001053</org_study_id>
    <nct_id>NCT02504554</nct_id>
  </id_info>
  <brief_title>Beneficial Bacteria Treatment</brief_title>
  <acronym>BBT</acronym>
  <official_title>Treating Gastrointestinal Problems in Children With Autism Using Beneficial Bacteria Treatment (BBT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northern Arizona University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Arizona State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label clinical trial to investigate a combination therapy for treating
      gastrointestinal problems in children with autism spectrum disorders.

      The combination therapy includes beneficial bacteria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an open-label clinical trial to evaluate the safety, tolerability, and feasibility of
      a combination therapy to treat gastrointestinal problems in children with autism spectrum
      disorders.

      It involves a combination therapy including beneficial bacteria.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastrointestinal Symptom Responsiveness Scale</measure>
    <time_frame>10 weeks</time_frame>
    <description>assessment of gastrointestinal symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parent Global Impressions-Revised</measure>
    <time_frame>10 weeks</time_frame>
    <description>assessment of autism and related symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood safety markers (assessment of blood chemistry panel and complete blood count)</measure>
    <time_frame>10 weeks</time_frame>
    <description>assessment of blood chemistry panel and complete blood count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Childhood Autism Rating Scale</measure>
    <time_frame>10 weeks</time_frame>
    <description>assessment of autism symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social Responsiveness Scale</measure>
    <time_frame>10 weeks</time_frame>
    <description>assessment of social skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Sensory Profile</measure>
    <time_frame>10 weeks</time_frame>
    <description>assessment of sensory sensitivity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vineland Adaptive Behavior Scale</measure>
    <time_frame>18 weeks</time_frame>
    <description>assessment of development</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stool diary</measure>
    <time_frame>10 weeks</time_frame>
    <description>assessment of constipation/diarrhea</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Gastrointestinal Problems</condition>
  <condition>Autism Spectrum Disorders</condition>
  <arm_group>
    <arm_group_label>Oral Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive all treatments orally. The treatments include a combination of Vancomycin, MoviPrep, Prilosec, and human fecal material; processed, frozen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rectal Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive some treatments rectally and some orally. The treatments include a combination of Vancomycin, MoviPrep, Prilosec, and human fecal material; processed, frozen.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral Vancomycin</intervention_name>
    <description>an antibiotic</description>
    <arm_group_label>Oral Group</arm_group_label>
    <arm_group_label>Rectal Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MoviPrep</intervention_name>
    <description>a bowel cleanse</description>
    <arm_group_label>Oral Group</arm_group_label>
    <arm_group_label>Rectal Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prilosec</intervention_name>
    <description>a stomach acid suppressan</description>
    <arm_group_label>Oral Group</arm_group_label>
    <arm_group_label>Rectal Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>human fecal material; processed, frozen administered orally</intervention_name>
    <description>human fecal material; processed, frozen, administered orally</description>
    <arm_group_label>Oral Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>human fecal material; processed, frozen; administered orally and rectally</intervention_name>
    <description>human fecal material; processed, frozen; administered orally and rectally</description>
    <arm_group_label>Rectal Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Children ages 7-17 years

          2. Diagnosis of autism per Autism Diagnostic Interview-Revised (ADI-R)

          3. Moderate or Severe GI problems ( on the GSRS, a single score of 4 (severe) on any
             item, or a score of 3 (moderate) on two items, or a score of 2 (mild) or more on any 4
             items

          4. No changes in medications, supplements, diet, therapies, or education in last 3
             months, and no intention to change them during clinical trial

          5. General good physical health aside from gastrointestinal problems

          6. Cognitive Ability to Provide Informed Assent

        Exclusion Criteria:

          1. Antibiotics in last 6 months

          2. Probiotics in last 3 months

          3. Single-gene disorder (Fragile X, etc.)

          4. Major brain malformation

          5. Tube feeding

          6. Severe gastrointestinal problems that require immediate treatment (life-threatening)

          7. Ulcerative Colitis, Crohn's Disease, diagnosed Celiac Disease, Eosinophilic
             Gastroenteritis, or similar conditions

          8. Severely underweight/malnourished

          9. Recent or scheduled surgeries

         10. Current participation in other clinical trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James B Adams, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona State University</affiliation>
  </overall_official>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2015</study_first_submitted>
  <study_first_submitted_qc>July 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>January 24, 2017</last_update_submitted>
  <last_update_submitted_qc>January 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autism Spectrum Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
    <mesh_term>Omeprazole</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 9, 2018</submitted>
    <returned>March 8, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

